fashion -WSS

fashion

author：explore 2025-09-27 23:03:32 - browse：2

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Judge in Trump's classified documents case questions use of out

WSS

Tuberculosis patients need more than just free medication

Sage considers ways to reduce costs following FDA rejection

Wegovy cuts risk of cardiovascular events by 20%, study finds

Astronauts get first look at the spacecraft that will fly them around the moon

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

focus

fashion

focus

Hepatitis C has a cure — but many Americans still lack access to it

Trump used to be more articulate. What could explain the change?

New air purifier tech could be key to improving indoor air quality

Sage's campaign to raise awareness of postpartum depression hits a nerve

ChatGPT in medicine: STAT answers readers' burning questions

Hospitals use virtual reality to design more inclusive rooms for kids

Moonlake's readout produced a cash windfall. Risks remain

FTX founder Sam Bankman

Medicare proposal to cover medical devices draws a mixed reaction

Failure, not just success, should guide future doctors

leisure time

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Judge in Trump's classified documents case questions use of out

Many breast cancer patients receive more radiation than needed

'Brian's Song' at 50 still offers lessons about cancer for today

Many breast cancer patients receive more radiation than needed

Google's generative AI to analyze medical images — and talk to docs

hotspot

focus

hotspot

entertainment